In another study on non-small cell lung cancer, experts attempted to predict the mutation status of target genes such as TP53 and KRAS using pathological images, and the AUC ranged from 0.733 to 0.856 in the external validation dataset (47). This evidence concerns the gene KRAS and non-small cell lung carcinoma.